Reoperation of a patient with the history of heparin-induced trombocytopenia

In this article, we present a 52-year-old male patient with mitral valve prosthesis with a history of HIT undergoing reoperation and aortic and tricuspid valve replacement in the light of literature review.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Patients who have heparin-induced thrombocytopenia (HIT) undergoing open heart surgery pose a particular problem to the cardiac surgery team.

📊

Key Findings & Data:Heparin is the gold standard for anticoagulation for the patients who are scheduled to undergo cardiopulmonary bypass.

💡

Conclusion & Impact:In this article, we present a 52-year-old male patient with mitral valve prosthesis with a history of HIT undergoing reoperation and aortic and tricuspid valve replacement in the light of literature review.

🔬Design:Review & Systematic Survey

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Patients who have heparin-induced thrombocytopenia (HIT) undergoing open heart surgery pose a particular problem to the cardiac surgery team. Heparin is the gold standard for anticoagulation for the patients who are scheduled to undergo cardiopulmonary bypass. Several management approaches with alternative anticoagulant agents are available for the patients with HIT requiring cardiopulmonary bypass. In this article, we present a 52-year-old male patient with mitral valve prosthesis with a history of HIT undergoing reoperation and aortic and tricuspid valve replacement in the light of literature review.

Özet

Heparine bağlı trombositopeni (HIT) olan ve açık kalp ameliyatı yapılması planlanan hastalar kalp cerrahisi ekibi için özel bir sorun oluşturur. Günümüzde kardiyopulmoner baypas ameliyatı alacak hastalarda antikoagülasyon için heparin altın standarttır. Kardiyopulmoner baypas kullanımı gerekli olan ve HIT olan hastalarda antikoagülan ajanlar ile çeşitli alternatif tedavi yaklaşımları da mevcuttur. Bu yazıda mitral protez kapağı olup, geçmişinde HIT öyküsü olan, tekrar ameliyat ile aort ve triküspit kapak replasmanı yapılan 52 yaşında bir erkek hasta, literatür eşliğinde sunuldu.

🔖

Cite This Article

KARAKİŞİ, O., ŞENER, E., ÇETİN, L., KUNT, A., HIDIROĞLU, M., KÜÇÜKER, A. (2022). Reoperation of a patient with the history of heparin-induced trombocytopenia. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 20 - Sayı: 4, 886–889. https://ajindex.com/articles/424677

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Koster A, Dyke CM, Aldea G, Smedira NG, McCarthy HL 2nd, Aronson S, et al. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg 2007;83:572-7. 2.Follis F, Schmidt CA. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg 2000;70:2173-81. 3.Gurbuz AT, Elliott WG, Zia AA. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. Eur J Cardiothorac Surg 2005;27:138- 49. 4.Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-31. 5.Hammon JW. Extracorporeal circulation: The response of humoral and cellular elements of blood to extracorporeal circulation. In: Cohn LH, editor. Cardiac surgery in the adult. Chapter 12B. New York: McGraw-Hill; 2008. p. 370-89. 6.Thielmann M, Bunschkowski M, Tossios P, Selleng S, Marggraf G, Greinacher A, et al. Perioperative thrombocytopenia in cardiac surgical patients - incidence of heparin-induced thrombocytopenia, morbidities and mortality. Eur J Cardiothorac Surg 2010;37:1391-5.